Journal of Cardiac Failure
Volume 15, Issue 6 , Pages 489-495 , August 2009

Preclinical Systolic and Diastolic Dysfunction Assessed by Tissue Doppler Imaging is Associated With Elevated Plasma Pro-B-type Natriuretic Peptide Concentrations

  • Rasmus Mogelvang, MD

      Affiliations

    • Copenhagen City Heart Study, Epidemiological Research Unit, Bispebjerg Hospital, Copenhagen, Denmark
    • Department of Cardiology, Gentofte Hospital, Hellerup, Denmark
    • Corresponding Author InformationCorrespondence to: Rasmus Mogelvang, MD, Department of Cardiology, Gentofte Hospital, Post 4210, 65 Niels Andersens Vej, DK-2900 Hellerup, Denmark. Tel: +45 26826407; Fax: +45 39777381.
    • ,
  • Jens P. Goetze, MD, DMSC

      Affiliations

    • Department of Clinical Biochemistry, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
    • ,
  • Sune A. Pedersen, MD

      Affiliations

    • Department of Cardiology, Gentofte Hospital, Hellerup, Denmark
    • ,
  • Niels T. Olsen, MD

      Affiliations

    • Department of Cardiology, Gentofte Hospital, Hellerup, Denmark
    • ,
  • Jacob L. Marott, MSc

      Affiliations

    • Copenhagen City Heart Study, Epidemiological Research Unit, Bispebjerg Hospital, Copenhagen, Denmark
    • ,
  • Peter Schnohr, MD

      Affiliations

    • Copenhagen City Heart Study, Epidemiological Research Unit, Bispebjerg Hospital, Copenhagen, Denmark
    • ,
  • Peter Sogaard, MD, DMSC

      Affiliations

    • Department of Cardiology, Gentofte Hospital, Hellerup, Denmark
    • ,
  • Jan S. Jensen, MD, PhD, DMSC

      Affiliations

    • Copenhagen City Heart Study, Epidemiological Research Unit, Bispebjerg Hospital, Copenhagen, Denmark
    • Department of Cardiology, Gentofte Hospital, Hellerup, Denmark

Received 21 September 2008 ,Revised 28 December 2008 ,Accepted 21 January 2009.

References 

  1. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068–3072
  2. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail. 2001;3:315–322
  3. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154–e235
  4. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115–1140
  5. Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194–202
  6. Nikitin NP, Witte KK. Application of tissue Doppler imaging in cardiology. Cardiology. 2004;101:170–184
  7. Yu CM, Sanderson JE, Marwick TH, Oh JK. Tissue Doppler imaging a new prognosticator for cardiovascular diseases. J Am Coll Cardiol. 2007;49:1903–1914
  8. Bruch C, Klem I, Breithardt G, Wichter T, Gradaus R. Diagnostic usefulness and prognostic implications of the mitral E/E' ratio in patients with heart failure and severe secondary mitral regurgitation. Am J Cardiol. 2007;100:860–865
  9. Nikitin NP, Loh PH, Silva R, Ghosh J, Khaleva OY, Goode K, et al. Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction. Heart. 2006;92:775–779
  10. Dokainish H, Zoghbi WA, Lakkis NM, Ambriz E, Patel R, Quinones MA, et al. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol. 2005;45:1223–1226
  11. Troughton RW, Prior DL, Frampton CM, Nash PJ, Pereira JJ, Martin M, et al. Usefulness of tissue Doppler and color M-mode indexes of left ventricular diastolic function in predicting outcomes in systolic left ventricular heart failure (from the ADEPT study). Am J Cardiol. 2005;96:257–262
  12. Wang M, Yip G, Yu CM, Zhang Q, Zhang Y, Tse D, et al. Independent and incremental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function. J Am Coll Cardiol. 2005;45:272–277
  13. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350:655–663
  14. Appleyard M, Hansen AT, Schnohr P, Jensen G, Nyboe J. The Copenhagen City Heart Study. A book of tables with data from the first examination (1976-78) and a five-year follow-up (1981-83). Scand J Soc Med. 1989;170:1–160
  15. Schnohr P, Jensen G, Lange P, Scharling H, Appleyard M. The Copenhagen City Heart Study. Tables with data from the third examination 1991-94. Eur Heart J. 2001;3:1–83
  16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252
  17. Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. JAMA. 1996;276:1246–1252
  18. Rowley KG, Daniel M, O'Dea K. Screening for diabetes in Indigenous populations using glycated hemoglobin: sensitivity, specificity, post-test likelihood and risk of disease. Diabet Med. 2005;22:833–839
  19. Rehfeld JF, Goetze JP. The posttranslational phase of gene expression: new possibilities in molecular diagnosis. Curr Mol Med. 2003;3:25–38
  20. Goetze JP, Kastrup J, Pedersen F, Rehfeld JF. Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. Clin Chem. 2002;48:1035–1042
  21. Goetze JP, Mogelvang R, Maage L, Scharling H, Schnohr P, Sogaard P, et al. Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction. Eur Heart J. 2006;27:3004–3010
  22. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–1463
  23. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–458
  24. Du Bois D, Du Bois EF. A formula to estimate the approximate surface if height and weight be known. Arch Intern Med. 1916;17:863–871
  25. Devereux RB, Dahlof B, Levy D, Pfeffer MA. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). Am J Cardiol. 1996;78:61–65
  26. Mogelvang R, Goetze JP, Schnohr P, Lange P, Sogaard P, Rehfeld JF, et al. Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide. J Am Coll Cardiol. 2007;50:1694–1701
  27. Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty A, Morehead A, et al. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol. 2004;43:416–422
  28. Vinereanu D, Lim PO, Frenneaux MP, Fraser AG. Reduced myocardial velocities of left ventricular long-axis contraction identify both systolic and diastolic heart failure—a comparison with brain natriuretic peptide. Eur J Heart Fail. 2005;7:512–519
  29. Vasan RS, Benjamin EJ, Larson MG, Leip EP, Wang TJ, Wilson PW, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA. 2002;288:1252–1259
  30. Kirkpatrick JN, Vannan MA, Narula J, Lang RM. Echocardiography in heart failure: applications, utility, and new horizons. J Am Coll Cardiol. 2007;50:381–396
  31. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: s comparative simultaneous Doppler-catheterization study. Circulation. 2000;102:1788–1794
  32. Kidawa M, Coignard L, Drobinski G, Krzeminska-Pakula M, Thomas D, Komajda M, et al. Comparative value of tissue Doppler imaging and m-mode color Doppler mitral flow propagation velocity for the evaluation of left ventricular filling pressure. Chest. 2005;128:2544–2550
  33. Firstenberg MS, Levine BD, Garcia MJ, Greenberg NL, Cardon L, Morehead AJ, et al. Relationship of echocardiographic indices to pulmonary capillary wedge pressures in healthy volunteers. J Am Coll Cardiol. 2000;36:1664–1669
  34. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part I: diagnosis, prognosis, and measurements of diastolic function. Circulation. 2002;105:1387–1393
  35. Yip GW, Zhang Y, Tan PY, Wang M, Ho PY, Brodin LA, et al. Left ventricular long-axis changes in early diastole and systole: impact of systolic function on diastole. Clin Sci (Lond). 2002;102:515–522
  36. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC. Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40:976–982
  37. McDonagh TA, Holmer S, Raymond I, Luchner A, Hildebrandt PR, Dargie HJ. NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur J Heart Fail. 2004;6:269–273
  38. Wu AH. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. Am Heart J. 2006;152:828–834
  39. Balion CM, McKelvie RS, Reichert S, Santaguida P, Booker L, Worster A, et al. Monitoring the response to pharmacologic therapy in patients with stable chronic heart failure: is BNP or NT-proBNP a useful assessment tool?. Clin Biochem. 2008;41:266–276
  40. Fang ZY, Leano R, Marwick TH. Relationship between longitudinal and radial contractility in subclinical diabetic heart disease. Clin Sci (Lond). 2004;106:53–60
  41. Przewlocka-Kosmala M, Kosmala W, Mazurek W. Left ventricular circumferential function in patients with essential hypertension. J Hum Hypertens. 2006;20:666–671

 Supported by grants from the Lundbeck Foundation, the Novo Nordisk Foundation, the Copenhagen County Research Foundation, the C.C. Klestrup Foundation, the Foundation Promoting Medicine, the Lykfeldt Foundation, the CM Sorensen and Wife's Foundation, and The Danish Heart Foundation (07-10-R60-A1698-B132-22413), Copenhagen, Denmark. Peter Sogaard has received honoraria from GE Healthcare. The sponsors had no role in the study design, data collection, data analysis, data interpretation nor in the writing of the manuscript.

PII: S1071-9164(09)00020-7

doi: 10.1016/j.cardfail.2009.01.005

Journal of Cardiac Failure
Volume 15, Issue 6 , Pages 489-495 , August 2009

Article Tools

* Image Usage & Resolution